en

PRODUCT DETAIL

Imraldi 40 mg/0,8 ml injekčný roztok

Code 2446D
MA number EU/1/17/1216/009
Product Form: sol inj 2x(1 liek.inj.skl+1 striek.+1 ihla+1 adaptér na liek.inj.skl.)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 59 - IMMUNOPRAEPARATA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L04 Immunosuppressants
L04A Immunosuppressants
L04AB Tumor necrosis factor alpha (TNF-alpha) inhibitors
L04AB04 Adalimumab
Shelf life: 36
Route of admin.: Subcutaneous use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 10(4) similar biological application
MA issued: 26.08.2019
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 05.05.2022
eu-flag.png sk-flag.png